OCT Future of Trials Conference: Decentralized, Direct-to-Patient& Virtual Clinical Trials

Leveraging DCT Solutions to Increase the Footprint of Sites, Improve Patient Access, and Trial Diversity

Watch on demand

All too often, decentralized clinical trials (DCTs) are characterized as 'site-less trials'. Yet, the reality is that DCT strategies can empower sites to reach more patients, decrease enrollment timelines, and capture more frequent data through remote patient monitoring.

Thus, we invite you to join Medable's site advisory council and DCT experts as they use real word examples to show how weaving DCT strategies into protocol design empowers sites to streamline, improve, and expand their capabilities. Attendees will walk away with an understanding of how to:

  • Increase Site Activation and Shorten Enrollment Timelines
  • Broaden Site Footprints with Remote Data Capture
  • Reduce Site and Patient Burden Using Digital Tools

Our speakers

Alison (Ali) Holland is Head of Decentralized Clinical Trials at Medable and is chartered to design and expand the end-to-end capabilities.

As Chief Scientific Officer, Dr. Pamela Tenaerts oversees Medable’s clinical research department to help identify, develop and implement...

Mary Costello has spent over thirty years in the healthcare and clinical research fields, working in commercial leadership roles with lar...

Watch on demand